+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy



Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy



Acta Oto-Laryngologica 123(1): 46-50



The efficacy of defibrinogenation therapy for idiopathic sudden sensorineural hearing loss was studied in comparison with high-dose steroid therapy. Eighty-eight consecutive patients with hearing levels > 40 dB and who had suffered hearing loss for < or = 30 days were enrolled: 40 patients for high-dose steroid therapy (PSL group) and 48 for defibrinogenation therapy (BX group). Hearing recovery was evaluated by grade assessment and by the improvement in hearing compared to the unaffected contralateral ear. The overall hearing outcomes of the two groups were roughly equivalent. However, with regard to patients with initial hearing levels < 80 dB, the hearing improvement rate of the BX group was significantly worse than that of the PSL group (61.2% +/- 7.3% vs 88.7% +/- 8.9%; p < 0.05), whereas in patients with initial hearing levels > or = 80 dB, the hearing outcomes did not differ between the 2 groups. Three patients in the PSL group manifested hyperglycemia while no serious side-effects were observed in the BX group. These results indicate that high-dose steroid therapy should be employed in preference to defibrinogenation therapy for patients with moderate hearing loss, whereas defibrinogenation therapy has an advantage for those with severe hearing loss, in view of its lower frequency of side-effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048723663

Download citation: RISBibTeXText

PMID: 12625572

DOI: 10.1080/0036554021000028082


Related references

Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Acta Oto-Laryngologica 133(5): 428-433, 2013

Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss. Otolaryngology--Head and Neck Surgery 134(5): 783-787, 2006

Does addition of antiviral medication to high-dose corticosteroid therapy improve hearing recovery following idiopathic sudden sensorineural hearing loss?. Laryngoscope 121(11): 2280-2281, 2011

Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 122(5): 1154-1157, 2012

Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss. Audiology and Neuro-Otology 18(3): 161-170, 2013

A comparison between systemic and intratympanic steroid therapies as initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis. Acta Oto-Laryngologica 137(6): 598-605, 2017

The Role of High Dose Intratympanic Dexamethasone as Salvage Therapy for Idiopathic Sudden Sensorineural Hearing Loss. Journal of International Advanced Otology 13(3): 318-321, 2017

Hyperbaric Oxygen Therapy as Concurrent Treatment with Systemic Steroids for Idiopathic Sudden Sensorineural Hearing Loss: A Comparison of Three Different Steroid Treatments. Audiology and Neuro-Otology 23(3): 145-151, 2018

Combined therapy (intratympanic dexamethasone + high-dose prednisone taper) for idiopathic sudden sensorineural hearing loss. Otology and Neurotology 30(2): 254-5; Author Reply 255-6, 2009

Prognostic predictors of sudden sensorineural hearing loss in defibrinogenation therapy. Acta Oto-Laryngologica 136(3): 271-276, 2016

Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otology and Neurotology 29(4): 453-460, 2008

Intratympanic steroid therapy for treatment of idiopathic sudden sensorineural hearing loss. Missouri Medicine 111(4): 352-356, 2014

Therapy of idiopathic sudden sensorineural hearing loss with intratympanic steroid injection. Journal of the Medical Association of Thailand 94(12): 1495-1499, 2011

Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss. Laryngoscope Investigative Otolaryngology 3(2): 73-77, 2018

Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 264(8): 861-866, 2007